Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3

Identifieur interne : 000A19 ( Main/Exploration ); précédent : 000A18; suivant : 000A20

Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3

Auteurs : Rong Fu [République populaire de Chine] ; Peng Yang [République populaire de Chine] ; Zongwei Li [États-Unis] ; Wen Liu [République populaire de Chine] ; Sajid Amin [République populaire de Chine] ; Zhuoyu Li [République populaire de Chine]

Source :

RBID : PMC:6685981

Abstract

Colorectal cancer (CRC) is a common malignant gastrointestinal tumor with high mortality worldwide. Drug resistance and cytotoxicity to normal cells are the main causes of chemotherapeutic treatment failure in CRC. Therefore, extracting the bioactive compounds from natural products with anti-carcinogenic activity and minimal side-effects is a promising strategy against CRC. The present study aims to evaluate the anti-carcinogenic properties of avenanthramides (AVNs) extracted from oats bran and clarify the underlying molecular mechanisms. We demonstrated that AVNs treatment suppressed mitochondrial bioenergetic generation, resulting in mitochondrial swelling and increased reactive oxygen species (ROS) production. Further study indicated that AVNs treatment significantly reduced DDX3 expression, an oncogenic RNA helicase highly expressed in human CRC tissues. DDX3 overexpression reversed the ROS-mediated CRC apoptosis induced by AVNs. Of note, we identified Avenanthramide A (AVN A) as the effective ingredient in AVNs extracts. AVN A blocked the ATPase activity of DDX3 and induced its degradation by directly binding to the Arg287 and Arg294 residues in DDX3. In conclusion, these innovative findings highlight that AVNs extracts, in particular its bioactive compound AVN A may crack the current hurdles in the way of CRC treatment.


Url:
DOI: 10.1038/s41419-019-1825-5
PubMed: 31391454
PubMed Central: 6685981


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3</title>
<author>
<name sortKey="Fu, Rong" sort="Fu, Rong" uniqKey="Fu R" first="Rong" last="Fu">Rong Fu</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institutes of Biomedical Sciences,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yang, Peng" sort="Yang, Peng" uniqKey="Yang P" first="Peng" last="Yang">Peng Yang</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institutes of Biomedical Sciences,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Li, Zongwei" sort="Li, Zongwei" uniqKey="Li Z" first="Zongwei" last="Li">Zongwei Li</name>
<affiliation wicri:level="2">
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id>
<institution-id institution-id-type="GRID">grid.240145.6</institution-id>
<institution>Department of Lymphoma and Myeloma, Center for Cancer Immunology Research,</institution>
<institution>The University of Texas MD Anderson Cancer Center,</institution>
</institution-wrap>
Houston, Texas 77030 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Liu, Wen" sort="Liu, Wen" uniqKey="Liu W" first="Wen" last="Liu">Wen Liu</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Amin, Sajid" sort="Amin, Sajid" uniqKey="Amin S" first="Sajid" last="Amin">Sajid Amin</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Li, Zhuoyu" sort="Li, Zhuoyu" uniqKey="Li Z" first="Zhuoyu" last="Li">Zhuoyu Li</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="Aff4">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>School of Life Science,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">31391454</idno>
<idno type="pmc">6685981</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685981</idno>
<idno type="RBID">PMC:6685981</idno>
<idno type="doi">10.1038/s41419-019-1825-5</idno>
<date when="2019">2019</date>
<idno type="wicri:Area/Pmc/Corpus">000066</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000066</idno>
<idno type="wicri:Area/Pmc/Curation">000066</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000066</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000955</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000955</idno>
<idno type="wicri:Area/Ncbi/Merge">000892</idno>
<idno type="wicri:Area/Ncbi/Curation">000892</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000892</idno>
<idno type="wicri:Area/Main/Merge">000A19</idno>
<idno type="wicri:Area/Main/Curation">000A19</idno>
<idno type="wicri:Area/Main/Exploration">000A19</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3</title>
<author>
<name sortKey="Fu, Rong" sort="Fu, Rong" uniqKey="Fu R" first="Rong" last="Fu">Rong Fu</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institutes of Biomedical Sciences,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yang, Peng" sort="Yang, Peng" uniqKey="Yang P" first="Peng" last="Yang">Peng Yang</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institutes of Biomedical Sciences,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Li, Zongwei" sort="Li, Zongwei" uniqKey="Li Z" first="Zongwei" last="Li">Zongwei Li</name>
<affiliation wicri:level="2">
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id>
<institution-id institution-id-type="GRID">grid.240145.6</institution-id>
<institution>Department of Lymphoma and Myeloma, Center for Cancer Immunology Research,</institution>
<institution>The University of Texas MD Anderson Cancer Center,</institution>
</institution-wrap>
Houston, Texas 77030 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Houston</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Liu, Wen" sort="Liu, Wen" uniqKey="Liu W" first="Wen" last="Liu">Wen Liu</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Amin, Sajid" sort="Amin, Sajid" uniqKey="Amin S" first="Sajid" last="Amin">Sajid Amin</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Li, Zhuoyu" sort="Li, Zhuoyu" uniqKey="Li Z" first="Zhuoyu" last="Li">Zhuoyu Li</name>
<affiliation wicri:level="1">
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="Aff4">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1760 2008</institution-id>
<institution-id institution-id-type="GRID">grid.163032.5</institution-id>
<institution>School of Life Science,</institution>
<institution>Shanxi University,</institution>
</institution-wrap>
Taiyuan, 030006 China</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Taiyuan</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cell Death & Disease</title>
<idno type="eISSN">2041-4889</idno>
<imprint>
<date when="2019">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="Par1">Colorectal cancer (CRC) is a common malignant gastrointestinal tumor with high mortality worldwide. Drug resistance and cytotoxicity to normal cells are the main causes of chemotherapeutic treatment failure in CRC. Therefore, extracting the bioactive compounds from natural products with anti-carcinogenic activity and minimal side-effects is a promising strategy against CRC. The present study aims to evaluate the anti-carcinogenic properties of avenanthramides (AVNs) extracted from oats bran and clarify the underlying molecular mechanisms. We demonstrated that AVNs treatment suppressed mitochondrial bioenergetic generation, resulting in mitochondrial swelling and increased reactive oxygen species (ROS) production. Further study indicated that AVNs treatment significantly reduced DDX3 expression, an oncogenic RNA helicase highly expressed in human CRC tissues. DDX3 overexpression reversed the ROS-mediated CRC apoptosis induced by AVNs. Of note, we identified Avenanthramide A (AVN A) as the effective ingredient in AVNs extracts. AVN A blocked the ATPase activity of DDX3 and induced its degradation by directly binding to the Arg287 and Arg294 residues in DDX3. In conclusion, these innovative findings highlight that AVNs extracts, in particular its bioactive compound AVN A may crack the current hurdles in the way of CRC treatment.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Brenner, H" uniqKey="Brenner H">H Brenner</name>
</author>
<author>
<name sortKey="Kloor, M" uniqKey="Kloor M">M Kloor</name>
</author>
<author>
<name sortKey="Pox, Cp" uniqKey="Pox C">CP Pox</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shanmugam, Mk" uniqKey="Shanmugam M">MK Shanmugam</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yu, X" uniqKey="Yu X">X Yu</name>
</author>
<author>
<name sortKey="Yang, M" uniqKey="Yang M">M Yang</name>
</author>
<author>
<name sortKey="Dong, J" uniqKey="Dong J">J Dong</name>
</author>
<author>
<name sortKey="Shen, R" uniqKey="Shen R">R Shen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Meydani, M" uniqKey="Meydani M">M Meydani</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ishihara, A" uniqKey="Ishihara A">A Ishihara</name>
</author>
<author>
<name sortKey="Kojima, K" uniqKey="Kojima K">K Kojima</name>
</author>
<author>
<name sortKey="Fujita, T" uniqKey="Fujita T">T Fujita</name>
</author>
<author>
<name sortKey="Yamamoto, Y" uniqKey="Yamamoto Y">Y Yamamoto</name>
</author>
<author>
<name sortKey="Nakajima, H" uniqKey="Nakajima H">H Nakajima</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Scarpa, Es" uniqKey="Scarpa E">ES Scarpa</name>
</author>
<author>
<name sortKey="Antonini, E" uniqKey="Antonini E">E Antonini</name>
</author>
<author>
<name sortKey="Palma, F" uniqKey="Palma F">F Palma</name>
</author>
<author>
<name sortKey="Mari, M" uniqKey="Mari M">M Mari</name>
</author>
<author>
<name sortKey="Ninfali, P" uniqKey="Ninfali P">P Ninfali</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bhola, Pd" uniqKey="Bhola P">PD Bhola</name>
</author>
<author>
<name sortKey="Letai, A" uniqKey="Letai A">A Letai</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sabharwal, Ss" uniqKey="Sabharwal S">SS Sabharwal</name>
</author>
<author>
<name sortKey="Schumacker, Pt" uniqKey="Schumacker P">PT Schumacker</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bol, Gm" uniqKey="Bol G">GM Bol</name>
</author>
<author>
<name sortKey="Xie, M" uniqKey="Xie M">M Xie</name>
</author>
<author>
<name sortKey="Raman, V" uniqKey="Raman V">V Raman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wu, Dw" uniqKey="Wu D">DW Wu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="He, Ty" uniqKey="He T">TY He</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wu, Dw" uniqKey="Wu D">DW Wu</name>
</author>
<author>
<name sortKey="Lin, Pl" uniqKey="Lin P">PL Lin</name>
</author>
<author>
<name sortKey="Wang, L" uniqKey="Wang L">L Wang</name>
</author>
<author>
<name sortKey="Huang, Cc" uniqKey="Huang C">CC Huang</name>
</author>
<author>
<name sortKey="Lee, H" uniqKey="Lee H">H Lee</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hitayezu, R" uniqKey="Hitayezu R">R Hitayezu</name>
</author>
<author>
<name sortKey="Jason Kinnin, Mmb" uniqKey="Jason Kinnin M">MMB Jason Kinnin</name>
</author>
<author>
<name sortKey="Henderson, K" uniqKey="Henderson K">K Henderson</name>
</author>
<author>
<name sortKey="Tsopmo, A" uniqKey="Tsopmo A">A Tsopmo</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dehne, N" uniqKey="Dehne N">N Dehne</name>
</author>
<author>
<name sortKey="Mora, J" uniqKey="Mora J">J Mora</name>
</author>
<author>
<name sortKey="Namgaladze, D" uniqKey="Namgaladze D">D Namgaladze</name>
</author>
<author>
<name sortKey="Weigert, A" uniqKey="Weigert A">A Weigert</name>
</author>
<author>
<name sortKey="Brune, B" uniqKey="Brune B">B Brune</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Plitzko, B" uniqKey="Plitzko B">B Plitzko</name>
</author>
<author>
<name sortKey="Kaweesa, En" uniqKey="Kaweesa E">EN Kaweesa</name>
</author>
<author>
<name sortKey="Loesgen, S" uniqKey="Loesgen S">S Loesgen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shrotriya, S" uniqKey="Shrotriya S">S Shrotriya</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Stevens, Jf" uniqKey="Stevens J">JF Stevens</name>
</author>
<author>
<name sortKey="Revel, Js" uniqKey="Revel J">JS Revel</name>
</author>
<author>
<name sortKey="Maier, Cs" uniqKey="Maier C">CS Maier</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Heerma Van Voss, Mr" uniqKey="Heerma Van Voss M">MR Heerma van Voss</name>
</author>
<author>
<name sortKey="Vesuna, F" uniqKey="Vesuna F">F Vesuna</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wilky, Ba" uniqKey="Wilky B">BA Wilky</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhang, L" uniqKey="Zhang L">L Zhang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bol, Gm" uniqKey="Bol G">GM Bol</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Klemm, F" uniqKey="Klemm F">F Klemm</name>
</author>
<author>
<name sortKey="Joyce, Ja" uniqKey="Joyce J">JA Joyce</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Taylor, S" uniqKey="Taylor S">S Taylor</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Nakazawa, Ms" uniqKey="Nakazawa M">MS Nakazawa</name>
</author>
<author>
<name sortKey="Keith, B" uniqKey="Keith B">B Keith</name>
</author>
<author>
<name sortKey="Simon, Mc" uniqKey="Simon M">MC Simon</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Weinberg, Se" uniqKey="Weinberg S">SE Weinberg</name>
</author>
<author>
<name sortKey="Chandel, Ns" uniqKey="Chandel N">NS Chandel</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ariumi, Y" uniqKey="Ariumi Y">Y Ariumi</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fu, J" uniqKey="Fu J">J Fu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chikara, S" uniqKey="Chikara S">S Chikara</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hussain, Ss" uniqKey="Hussain S">SS Hussain</name>
</author>
<author>
<name sortKey="Kumar, Ap" uniqKey="Kumar A">AP Kumar</name>
</author>
<author>
<name sortKey="Ghosh, R" uniqKey="Ghosh R">R Ghosh</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Cui, L" uniqKey="Cui L">L Cui</name>
</author>
<author>
<name sortKey="Liu, J" uniqKey="Liu J">J Liu</name>
</author>
<author>
<name sortKey="Yan, X" uniqKey="Yan X">X Yan</name>
</author>
<author>
<name sortKey="Hu, S" uniqKey="Hu S">S Hu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yang, P" uniqKey="Yang P">P Yang</name>
</author>
<author>
<name sortKey="Li, Z" uniqKey="Li Z">Z Li</name>
</author>
<author>
<name sortKey="Fu, R" uniqKey="Fu R">R Fu</name>
</author>
<author>
<name sortKey="Wu, H" uniqKey="Wu H">H Wu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yang, P" uniqKey="Yang P">P Yang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Huang, R" uniqKey="Huang R">R Huang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chen, L" uniqKey="Chen L">L Chen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Samal, Sk" uniqKey="Samal S">SK Samal</name>
</author>
<author>
<name sortKey="Routray, S" uniqKey="Routray S">S Routray</name>
</author>
<author>
<name sortKey="Veeramachaneni, Gk" uniqKey="Veeramachaneni G">GK Veeramachaneni</name>
</author>
<author>
<name sortKey="Dash, R" uniqKey="Dash R">R Dash</name>
</author>
<author>
<name sortKey="Botlagunta, M" uniqKey="Botlagunta M">M Botlagunta</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ding, Gb" uniqKey="Ding G">GB Ding</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
</region>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Fu, Rong" sort="Fu, Rong" uniqKey="Fu R" first="Rong" last="Fu">Rong Fu</name>
</noRegion>
<name sortKey="Amin, Sajid" sort="Amin, Sajid" uniqKey="Amin S" first="Sajid" last="Amin">Sajid Amin</name>
<name sortKey="Fu, Rong" sort="Fu, Rong" uniqKey="Fu R" first="Rong" last="Fu">Rong Fu</name>
<name sortKey="Li, Zhuoyu" sort="Li, Zhuoyu" uniqKey="Li Z" first="Zhuoyu" last="Li">Zhuoyu Li</name>
<name sortKey="Li, Zhuoyu" sort="Li, Zhuoyu" uniqKey="Li Z" first="Zhuoyu" last="Li">Zhuoyu Li</name>
<name sortKey="Liu, Wen" sort="Liu, Wen" uniqKey="Liu W" first="Wen" last="Liu">Wen Liu</name>
<name sortKey="Yang, Peng" sort="Yang, Peng" uniqKey="Yang P" first="Peng" last="Yang">Peng Yang</name>
<name sortKey="Yang, Peng" sort="Yang, Peng" uniqKey="Yang P" first="Peng" last="Yang">Peng Yang</name>
</country>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Li, Zongwei" sort="Li, Zongwei" uniqKey="Li Z" first="Zongwei" last="Li">Zongwei Li</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A19 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A19 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:6685981
   |texte=   Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31391454" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021